Social Phobia Clinical Trial
Official title:
VR Mind™ and VR Mind +™ Intervention - Randomized, Open Label, Single Masking, Parallel Group Clinical Trial
The aim of the study is to assess the safety and efficacy of VR Mind and VR Mind + interventions.
In this study, investigators will test the software developed by Tomorrow Sp. z o. o., named
VR Mind and VR Mind+. The software utilizes the concept of virtual reality exposure therapy
to treat social anxiety disorder. The aim of the study is to assess the safety and efficacy
of VR Mind and VR Mind + interventions.
The research consists of fourteen sessions. The first and the last session will be dedicated
to participant assessment. Subsequent sessions 2-13 will be performed according to the
therapy protocol for each arm. Control group of participants (active comparative arm) will
receive standard treatment for social anxiety disorder - cognitive behavioral therapy based
on the protocol developed by the Principal Investigator [protocol adapted from the approach
of Clark and Wells (Mayo-Wilson, Dias, Mavranezouli, 2014)]. Experimental group 1 will
receive cognitive behavioral therapy with exposure in virtual environment. Experimental group
1 and control group were designed to be as similar as possible, with the exception of the
modality for the delivery of exposure. All treatment session will be led by licensed
therapist.
Participants of the experimental group 2 will independently conducts the self-therapy
process. The intervention will consist of 12 therapeutic sessions. At each of the 12
sessions, the participant will selects a specific scenario of social situations that arouse
fear (e.g. public speaking, job interview or other situations from everyday life).
Because of the risk of simulator sickness (e.g., headaches, nausea), exposure trials will
last no longer than 20 minutes for each session.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT01570400 -
Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT
|
N/A | |
Recruiting |
NCT01388231 -
Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice
|
Phase 2/Phase 3 | |
Completed |
NCT00684541 -
Interpretation Modification Program for Social Phobia
|
N/A | |
Completed |
NCT00434759 -
Social Phobia Intervention Study of Mannheim
|
N/A | |
Completed |
NCT00380731 -
Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
|
N/A | |
Completed |
NCT03647605 -
Pilot Study: VR Mind and VR Mind+ Intervention
|
N/A | |
Not yet recruiting |
NCT03241277 -
Nonsurgical Periodontal Treatment in Patients With Social Phobia
|
N/A | |
Completed |
NCT02648737 -
Cognitive Behavioural Therapy for Anxiety Disorders in PD
|
N/A | |
Completed |
NCT02294409 -
Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis
|
N/A | |
Terminated |
NCT01979263 -
Attention Bias Modification Treatment for Anxious Youth
|
N/A | |
Completed |
NCT01463137 -
Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder
|
N/A | |
Completed |
NCT00774150 -
Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study
|
N/A | |
Completed |
NCT00264654 -
Long-term Study Of Paroxetine in Women and Men
|
Phase 3 | |
Completed |
NCT00326430 -
Residential Cognitive and Interpersonal Therapy for Social Phobia
|
Phase 2/Phase 3 | |
Completed |
NCT00000389 -
Treatment for Anxiety in Children
|
Phase 3 | |
Completed |
NCT00397722 -
Treatment Of Patients With Social Anxiety Disorder
|
Phase 2 | |
Completed |
NCT02678624 -
Project Collabri for Treatment of Anxiety
|
N/A | |
Completed |
NCT00564967 -
A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy
|
Phase 3 | |
Completed |
NCT00403962 -
A Combination Therapy In Patients With Social Anxiety Disorder
|
Phase 2 |